240 related articles for article (PubMed ID: 21318594)
1. Bioavailability of dexmedetomidine after intranasal administration.
Iirola T; Vilo S; Manner T; Aantaa R; Lahtinen M; Scheinin M; Olkkola KT
Eur J Clin Pharmacol; 2011 Aug; 67(8):825-31. PubMed ID: 21318594
[TBL] [Abstract][Full Text] [Related]
2. Mechanism-based population pharmacokinetic and pharmacodynamic modeling of intravenous and intranasal dexmedetomidine in healthy subjects.
Yoo H; Iirola T; Vilo S; Manner T; Aantaa R; Lahtinen M; Scheinin M; Olkkola KT; Jusko WJ
Eur J Clin Pharmacol; 2015 Oct; 71(10):1197-207. PubMed ID: 26233335
[TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine Pharmacology in Neonates and Infants After Open Heart Surgery.
Su F; Gastonguay MR; Nicolson SC; DiLiberto M; Ocampo-Pelland A; Zuppa AF
Anesth Analg; 2016 May; 122(5):1556-66. PubMed ID: 26218862
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and Sedative Effects of Intranasal Dexmedetomidine in Ambulatory Pediatric Patients.
Uusalo P; Guillaume S; Siren S; Manner T; Vilo S; Scheinin M; Saari TI
Anesth Analg; 2020 Apr; 130(4):949-957. PubMed ID: 31206433
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of intravenous dexmedetomidine in healthy Korean subjects.
Lee S; Kim BH; Lim K; Stalker D; Wisemandle W; Shin SG; Jang IJ; Yu KS
J Clin Pharm Ther; 2012 Dec; 37(6):698-703. PubMed ID: 22650799
[TBL] [Abstract][Full Text] [Related]
6. Does intranasal dexmedetomidine provide adequate plasma concentrations for sedation in children: a pharmacokinetic study.
Miller JW; Balyan R; Dong M; Mahmoud M; Lam JE; Pratap JN; Paquin JR; Li BL; Spaeth JP; Vinks A; Loepke AW
Br J Anaesth; 2018 May; 120(5):1056-1065. PubMed ID: 29661383
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic and pharmacodynamic study of intranasal and intravenous dexmedetomidine.
Li A; Yuen VM; Goulay-Dufaÿ S; Sheng Y; Standing JF; Kwok PCL; Leung MKM; Leung AS; Wong ICK; Irwin MG
Br J Anaesth; 2018 May; 120(5):960-968. PubMed ID: 29661413
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneously administered dexmedetomidine is efficiently absorbed and is associated with attenuated cardiovascular effects in healthy volunteers.
Uusalo P; Al-Ramahi D; Tilli I; Aantaa RA; Scheinin M; Saari TI
Eur J Clin Pharmacol; 2018 Aug; 74(8):1047-1054. PubMed ID: 29666901
[TBL] [Abstract][Full Text] [Related]
9. Intranasal dexmedetomidine in healthy beagles: An echocardiographic and pharmacokinetic/pharmacodynamic study.
Santangelo B; Harel M; Fourel I; Micieli F; Cataldi M; Segard-Weisse E; Portier K
Vet J; 2019 Sep; 251():105346. PubMed ID: 31492384
[TBL] [Abstract][Full Text] [Related]
10. Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine.
Weerink MAS; Struys MMRF; Hannivoort LN; Barends CRM; Absalom AR; Colin P
Clin Pharmacokinet; 2017 Aug; 56(8):893-913. PubMed ID: 28105598
[TBL] [Abstract][Full Text] [Related]
11. The sedative effects of the intranasal administration of dexmedetomidine in children undergoing surgeries compared to other sedation methods: A systematic review and meta-analysis.
Kim HJ; Shin WJ; Park S; Ahn HS; Oh JH
J Clin Anesth; 2017 May; 38():33-39. PubMed ID: 28372674
[TBL] [Abstract][Full Text] [Related]
12. [Dexmedetomidine. Pharmacokinetics and pharmacodynamics].
Ihmsen H; Saari TI
Anaesthesist; 2012 Dec; 61(12):1059-66. PubMed ID: 23223843
[TBL] [Abstract][Full Text] [Related]
13. Plasma concentrations and sedative effects of a dexmedetomidine, midazolam, and butorphanol combination after transnasal administration in healthy rabbits.
Santangelo B; Micieli F; Marino F; Reynaud F; Cassandro P; Carfora A; Petrella R; Borriello R; Cataldi M; Vesce G
J Vet Pharmacol Ther; 2016 Aug; 39(4):408-11. PubMed ID: 26687556
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of a new highly concentrated intranasal midazolam formulation for conscious sedation.
Schrier L; Zuiker R; Merkus FW; Klaassen ES; Guan Z; Tuk B; van Gerven JM; van der Geest R; Groeneveld GJ
Br J Clin Pharmacol; 2017 Apr; 83(4):721-731. PubMed ID: 27780297
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and pharmacodynamic effects of oral transmucosal and intravenous administration of dexmedetomidine in dogs.
Dent BT; Aarnes TK; Wavreille VA; Lakritz J; Lerche P; KuKanich B; Riccó Pereira CH; Bednarski RM
Am J Vet Res; 2019 Oct; 80(10):969-975. PubMed ID: 31556717
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of intravenous dexmedetomidine in the horse.
Rezende ML; Grimsrud KN; Stanley SD; Steffey EP; Mama KR
J Vet Pharmacol Ther; 2015 Feb; 38(1):15-23. PubMed ID: 25066475
[TBL] [Abstract][Full Text] [Related]
17. Dexmedetomidine Pharmacokinetics and a New Dosing Paradigm in Infants Supported With Cardiopulmonary Bypass.
Zimmerman KO; Wu H; Laughon M; Greenberg RG; Walczak R; Schulman SR; Smith PB; Hornik CP; Cohen-Wolkowiez M; Watt KM
Anesth Analg; 2019 Dec; 129(6):1519-1528. PubMed ID: 31743171
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of dexmedetomidine, MK-467, and their combination following intravenous administration in male cats.
Pypendop BH; Honkavaara J; Ilkiw JE
J Vet Pharmacol Ther; 2016 Oct; 39(5):460-8. PubMed ID: 26896345
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, crossover assessment of the sedative and analgesic effects of intranasal dexmedetomidine.
Yuen VM; Irwin MG; Hui TW; Yuen MK; Lee LH
Anesth Analg; 2007 Aug; 105(2):374-80. PubMed ID: 17646493
[TBL] [Abstract][Full Text] [Related]
20. Electroencephalographic Arousal Patterns Under Dexmedetomidine Sedation.
Sleigh JW; Vacas S; Flexman AM; Talke PO
Anesth Analg; 2018 Oct; 127(4):951-959. PubMed ID: 29933272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
